MBBS · Pathology

Leukemia and lymphoma

Read the topic background here, then explore the labeled visual and structured learning explanations on this page.

Read explanation on this page ↓ See diagram ↓
Read here · Related subject background

Leukemia — on-site reading

This reference extract addresses Leukemia, a related subject. It does not cover every part of Leukemia and lymphoma.. The article introduction is reproduced here, so you do not need to leave MedAtlas to read it. It may not match the latest official medical guidance.

Leukemia (also spelled leukaemia; pronounced loo-KEE-mee-ə) is a group of blood cancers that usually begin in the bone marrow and produce high numbers of abnormal blood cells. These blood cells are not fully developed and are called blasts or leukemia cells. Signs and symptoms may include bleeding and bruising, bone pain, fatigue, fever, and an increased risk of infections. These symptoms occur due to a lack of normal blood cells. Diagnosis is typically made by blood tests or bone marrow biopsy.
The exact cause of leukemia is still under research. A combination of genetic factors and environmental (non-inherited) factors are believed to play a role. Risk factors include smoking, ionizing radiation, petrochemicals (such as benzene), prior chemotherapy, and Down syndrome. People with a family history of leukemia are also at higher risk. There are four main types of leukemia—acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML)—and a number of less common types. Leukemias and lymphomas both belong to a broader group of tumors that affect the blood, bone marrow, and lymphoid system, known as tumors of the hematopoietic and lymphoid tissues.
Treatment may involve some combination of chemotherapy, radiation therapy, targeted therapy, and bone marrow transplant, with supportive and palliative care provided as needed. Certain types of leukemia may be managed with watchful waiting. The success of treatment depends on the type of leukemia and the age of the person. Outcomes have improved in the developed world. Five-year survival rate was 69% in the United States in the period from 2016 to 2022. In children under 15 in first-world countries, the five-year survival rate is greater than 60% or even 90%, depending on the type of leukemia. For infants (those diagnosed under the age of 1), the survival rate is around 40%. In children who are cancer-free five years after diagnosis of acute leukemia, the cancer is unlikely to return.
In 2015, leukemia was present in 2.3 million people worldwide and caused 353,500 deaths. In 2012, it had newly developed in 352,000 people. It is the most common type of cancer in children, with three-quarters of leukemia cases in children being the acute lymphoblastic type. However, over 90% of all leukemias are diagnosed in adults, CLL and AML being the most common. It occurs more commonly in the developed world.

How this connects to Pathology

Blood and marrow disorders involve cell production and survival, immune function or the regulation of clotting and bleeding. A blood count or isolated biomarker is not a diagnosis: peripheral smear findings, cell lineage, clinical history and relevant marrow or molecular tests may be necessary.

Text credit: Wikipedia contributors, “Leukemia”, original article · authors & revision history · CC BY-SA 4.0. Unmodified opening extract, accessed 24 September 2026. This Wikipedia-derived section is provided under CC BY-SA 4.0; the independent MedAtlas notes and design are separate works.

On-site diagram

Leukemia and lymphoma · visual study map

Scalable vector illustration. Labeled conceptual map, not a precise anatomical, histological or diagnostic image.
TOPIC LEARNING MAP · NOT AN ANATOMICAL PLATE01 · BackgroundLeukemia (also spelled leukaemia;pronounced loo-KEE-mee-ə) is a group ofblood cancers that usually begin…02 · Main conceptThese blood cells are not fullydeveloped and are called blasts orleukemia cells.03 · Related processSigns and symptoms may include bleedingand bruising, bone pain, fatigue, fever,and an increased risk of…04 · Study connectionThese symptoms occur due to a lack ofnormal blood cells.Leukemia and lymphomaRead the full text below the visual · all reading is on this website

The wording in this learning map is adapted from the attributed Wikipedia background section below (CC BY-SA 4.0).

Study foundation 01

What the underlying subject studies

Pathology connects tissue and cellular changes to disease mechanisms. Begin with normal anatomy and physiology, describe what is disrupted, and distinguish an observed finding from its possible cause. A lesion pattern is often shared by several diseases.

Study foundation 02

How mechanisms and evidence connect

Organ injury may result from inflammation, ischemia, immune mechanisms, neoplasia, metabolic abnormalities or inherited conditions. The time course and host response influence morphology and clinical consequences.

Study foundation 03

How to develop a sound explanation

When studying a pathology topic, organize cause, mechanism, macro- and microscopic features, consequences and key differentials. Real diagnoses require clinical context, representative tissue and appropriate laboratory or imaging correlation.

References and verification (optional)

All reading material on this page appears above. The links below are for checking the primary syllabus, research or source attribution, not requirements for opening this lesson.

NMC official CBME Curriculum 2024 and current regulations index ↗

Find research on Leukemia and lymphoma ↗